1 reports of this reaction
10.0% of all Mounjaro reports
#8 most reported adverse reaction
NECROTISING FASCIITIS is the #8 most commonly reported adverse reaction for Mounjaro, manufactured by Eli Lilly and Company. There are 1 FDA adverse event reports linking Mounjaro to NECROTISING FASCIITIS. This represents approximately 10.0% of all 10 adverse event reports for this drug.
Patients taking Mounjaro who experience necrotising fasciitis should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
NECROTISING FASCIITIS is moderately reported among Mounjaro users, representing a notable but not dominant share of adverse events.
In addition to necrotising fasciitis, the following adverse reactions have been reported for Mounjaro:
NECROTISING FASCIITIS has been reported as an adverse event in 1 FDA reports for Mounjaro. This does not prove causation, but indicates an association observed in post-market surveillance data.
NECROTISING FASCIITIS accounts for approximately 10.0% of all adverse event reports for Mounjaro, making it a notable side effect.
If you experience necrotising fasciitis while taking Mounjaro, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.